Axogen Inc Stock Fundamentals
| AXGN Stock | USD 17.25 0.09 0.52% |
Axogen Inc fundamentals help investors to digest information that contributes to Axogen's financial success or failures. It also enables traders to predict the movement of Axogen Stock. The fundamental analysis module provides a way to measure Axogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axogen stock.
At this time, Axogen's Cost Of Revenue is very stable compared to the past year. As of the 15th of March 2025, Total Operating Expenses is likely to grow to about 152.5 M, while Operating Income is likely to drop (3.5 M). Axogen | Select Account or Indicator |
Axogen Inc Company Current Valuation Analysis
Axogen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Axogen Current Valuation | 801.02 M |
Most of Axogen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Axogen Current Valuation Historical Pattern
Today, most investors in Axogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Axogen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Axogen current valuation as a starting point in their analysis.
Axogen Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Axogen Inc has a Current Valuation of 801.02 M. This is 94.42% lower than that of the Health Care Equipment & Supplies sector and 93.55% lower than that of the Health Care industry. The current valuation for all United States stocks is 95.18% higher than that of the company.
Axogen Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Axogen's current stock value. Our valuation model uses many indicators to compare Axogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axogen competition to find correlations between indicators driving Axogen's intrinsic value. More Info.Axogen Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Axogen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axogen's earnings, one of the primary drivers of an investment's value.Axogen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axogen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axogen could also be used in its relative valuation, which is a method of valuing Axogen by comparing valuation metrics of similar companies.Axogen is currently under evaluation in current valuation category among its peers.
Axogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Axogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Axogen's managers, analysts, and investors.Environmental | Governance | Social |
Axogen Fundamentals
| Return On Equity | -0.0999 | ||||
| Return On Asset | -0.0103 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 801.02 M | ||||
| Shares Outstanding | 44.34 M | ||||
| Shares Owned By Insiders | 5.49 % | ||||
| Shares Owned By Institutions | 81.94 % | ||||
| Number Of Shares Shorted | 1.85 M | ||||
| Price To Earning | (47.07) X | ||||
| Price To Book | 7.37 X | ||||
| Price To Sales | 4.08 X | ||||
| Revenue | 187.34 M | ||||
| Gross Profit | 141.98 M | ||||
| EBITDA | 6.08 M | ||||
| Net Income | (9.96 M) | ||||
| Cash And Equivalents | 58.03 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 68.69 M | ||||
| Debt To Equity | 0.71 % | ||||
| Current Ratio | 4.52 X | ||||
| Book Value Per Share | 2.35 X | ||||
| Cash Flow From Operations | 4.54 M | ||||
| Short Ratio | 3.87 X | ||||
| Earnings Per Share | (0.23) X | ||||
| Target Price | 25.0 | ||||
| Number Of Employees | 451 | ||||
| Beta | 1.02 | ||||
| Market Capitalization | 764.93 M | ||||
| Total Asset | 203.73 M | ||||
| Retained Earnings | (291.26 M) | ||||
| Working Capital | 68.61 M | ||||
| Current Asset | 35.05 M | ||||
| Current Liabilities | 3.71 M | ||||
| Net Asset | 203.73 M |
About Axogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 12.6 K | 12 K | |
| Total Revenue | 187.3 M | 196.7 M | |
| Cost Of Revenue | 45.4 M | 47.6 M | |
| Stock Based Compensation To Revenue | 0.08 | 0.08 | |
| Sales General And Administrative To Revenue | 0.21 | 0.36 | |
| Research And Ddevelopement To Revenue | 0.15 | 0.10 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 4.23 | 4.44 | |
| Ebit Per Revenue | (0.02) | (0.02) |
Pair Trading with Axogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.Moving against Axogen Stock
| 0.56 | EMBC | Embecta Corp | PairCorr |
| 0.56 | SRDX | SurModics | PairCorr |
| 0.54 | SMLR | Semler Scientific | PairCorr |
| 0.52 | TELA | Tela Bio Earnings Call This Week | PairCorr |
| 0.48 | DXR | Daxor | PairCorr |
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Axogen Piotroski F Score and Axogen Altman Z Score analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.23) | Revenue Per Share | Quarterly Revenue Growth 0.151 | Return On Assets | Return On Equity |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.